Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO) Enter $825 Million Deal for Alzheimer's Drug
3/26/2013 7:03:04 AM
More...
|
Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO) Wins Approval for Monthly Abilify Shot
3/1/2013 7:26:41 AM
More...
|
Lennox-Gastaut Syndrome Foundation and H. Lundbeck A/S (LUN.CO) Announce Scholarship
1/23/2013 9:51:51 AM
More...
|
Patient Groups Give H. Lundbeck A/S (LUN.CO) Top Marks
1/14/2013 8:43:56 AM
More...
|
H. Lundbeck A/S (LUN.CO) Appoints New Vice President of Global Pricing and Market Access
1/11/2013 9:35:15 AM
More...
|
Vernalis PLC (VNLPY.PK) and H. Lundbeck A/S (LUN.CO) Achieve Third Research Milestone
1/2/2013 10:11:45 AM
More...
|
H. Lundbeck A/S (LUN.CO) Invests Significantly in Product Development and Product Launches and Has Consequently Revised Its Financial Plans
12/19/2012 9:24:15 AM
More...
|
H. Lundbeck A/S (LUN.CO) Receives Positive Opinion for Approval of Selincro (Nalmefene) in the European Union
12/14/2012 9:55:23 AM
More...
|
FDA Accepts Takeda Pharmaceutical Co. Ltd. (TKPYY) and H. Lundbeck A/S (LUN.CO)’s Filing for Review of Brintellix (vortioxetine) for the Treatment of Major Depression
12/13/2012 9:54:53 AM
More...
|
Genmab A/S (GEN.CO) Reaches Third Milestone in H. Lundbeck A/S (LUN.CO) Collaboration
12/13/2012 9:51:41 AM
More...
|
|